Is Evoke Pharma, Inc. (EVOK) a Buy, Sell, or Hold?
NASDAQ : EVOK
Evoke Pharma, Inc.
$11 USD
$11 (0%)
- Volume
- 47.1K
- Average Volume
- 100.37K
- Market Capitalization
- $18.95M
- P/E Ratio
- -6.96
- Dividend Yield
- 0.00%
- Price Target
- $18.00
- Year High
- $11.00
- Year Low
- $1.94
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $1.27
NUMBER OF INSIDERS BUYING (LAST 12 MONTHS)
19
NUMBER OF INSIDERS SELLING (LAST 12 MONTHS)
40
AMOUNT OF INSIDER SELLING (LAST 12 MONTHS)
$1.52M
EVOK Estimated and Actual Revenue by Quarter
Get MSFT Insider Trade Alerts
EVOK Insider Trading History
| Insider Name | Title | Date | Transaction | Cost | Filing Date |
|---|---|---|---|---|---|
| Nantahala Capital Management, LLC | 10 percent owner | 2025-12-17 | J-Other | 11 | 2025-12-19 |
| Nantahala Capital Management, LLC | 10 percent owner | 2025-12-17 | J-Other | 0.0001 | 2025-12-19 |
| Nantahala Capital Management, LLC | 10 percent owner | 2025-12-17 | J-Other | 8.16 | 2025-12-19 |
| Nantahala Capital Management, LLC | 10 percent owner | 2025-12-17 | J-Other | 8.16 | 2025-12-19 |
| Nantahala Capital Management, LLC | 10 percent owner | 2025-12-17 | J-Other | 0.01 | 2025-12-19 |
| Nantahala Capital Management, LLC | 10 percent owner | 2025-12-17 | J-Other | 0.01 | 2025-12-19 |
| PYSZCZYMUKA GREG | director | 2025-12-17 | D-Return | 5.26 | 2025-12-17 |
| PYSZCZYMUKA GREG | director | 2025-12-17 | D-Return | 3.453 | 2025-12-17 |
| Smeal Benjamin C. | director | 2025-12-17 | D-Return | 5.51 | 2025-12-17 |
| Smeal Benjamin C. | director | 2025-12-17 | D-Return | 3.453 | 2025-12-17 |
| CARLSON MARILYN R. | officer: Chief Medical Officer | 2025-12-17 | D-Return | 5.27 | 2025-12-17 |
| CARLSON MARILYN R. | officer: Chief Medical Officer | 2025-12-17 | D-Return | 4.45 | 2025-12-17 |
| CARLSON MARILYN R. | officer: Chief Medical Officer | 2025-12-16 | U-Tender | 11 | 2025-12-17 |
| GARNER CAM L | director | 2025-12-16 | U-Tender | 11 | 2025-12-17 |
| GARNER CAM L | director | 2025-12-17 | D-Return | 3.453 | 2025-12-17 |
| GARNER CAM L | director | 2025-12-17 | D-Return | 4.45 | 2025-12-17 |
| GARNER CAM L | director | 2025-12-17 | D-Return | 5.41 | 2025-12-17 |
| Hill Malcolm R | director | 2025-12-17 | D-Return | 5.41 | 2025-12-17 |
| Hill Malcolm R | director | 2025-12-17 | D-Return | 4.45 | 2025-12-17 |
| Hill Malcolm R | director | 2025-12-17 | D-Return | 3.453 | 2025-12-17 |
| Hill Malcolm R | director | 2025-12-16 | U-Tender | 11 | 2025-12-17 |
| Kowieski Mark | officer: Chief Financial Officer | 2025-12-17 | D-Return | 5.27 | 2025-12-17 |
| Kowieski Mark | officer: Chief Financial Officer | 2025-12-17 | D-Return | 4.45 | 2025-12-17 |
| Kowieski Mark | officer: Chief Financial Officer | 2025-12-16 | U-Tender | 11 | 2025-12-17 |
| WIDDER KENNETH J | director | 2025-12-17 | D-Return | 3.453 | 2025-12-17 |
| WIDDER KENNETH J | director | 2025-12-17 | D-Return | 4.45 | 2025-12-17 |
| WIDDER KENNETH J | director | 2025-12-17 | D-Return | 5.41 | 2025-12-17 |
| Brady Todd C | director | 2025-12-17 | D-Return | 3.453 | 2025-12-17 |
| Brady Todd C | director | 2025-12-16 | U-Tender | 11 | 2025-12-17 |
| Brady Todd C | director | 2025-12-17 | D-Return | 5.41 | 2025-12-17 |
| Brady Todd C | director | 2025-12-17 | D-Return | 4.45 | 2025-12-17 |
| REED VICKIE S | director | 2025-12-17 | D-Return | 5.41 | 2025-12-17 |
| REED VICKIE S | director | 2025-12-17 | D-Return | 4.45 | 2025-12-17 |
| REED VICKIE S | director | 2025-12-17 | D-Return | 3.453 | 2025-12-17 |
| D'Onofrio Matthew J | director, officer: Chief Executive Officer | 2025-12-17 | D-Return | 4.45 | 2025-12-17 |
| D'Onofrio Matthew J | director, officer: Chief Executive Officer | 2025-12-16 | U-Tender | 11 | 2025-12-17 |
| D'Onofrio Matthew J | director, officer: Chief Executive Officer | 2025-12-17 | D-Return | 5.27 | 2025-12-17 |
| Klein Roger M. | 10 percent owner | 2025-11-06 | S-Sale | 10.65 | 2025-11-07 |
| Klein Roger M. | 10 percent owner | 2025-11-06 | S-Sale | 10.657 | 2025-11-07 |
| Klein Roger M. | 10 percent owner | 2025-11-04 | 0 | 2025-11-06 | |
| Klein Roger M. | 10 percent owner | 2025-11-04 | 0 | 2025-11-06 | |
| Brady Todd C | director | 2025-05-21 | A-Award | 3.453 | 2025-05-22 |
| Hill Malcolm R | director | 2025-05-21 | A-Award | 3.453 | 2025-05-22 |
| GARNER CAM L | director | 2025-05-21 | A-Award | 3.453 | 2025-05-22 |
| REED VICKIE S | director | 2025-05-21 | A-Award | 3.453 | 2025-05-22 |
| WIDDER KENNETH J | director | 2025-05-21 | A-Award | 3.453 | 2025-05-22 |
| Smeal Benjamin C. | director | 2025-05-21 | A-Award | 3.453 | 2025-05-22 |
| PYSZCZYMUKA GREG | director | 2025-05-21 | A-Award | 3.453 | 2025-05-22 |
| D'Onofrio Matthew J | director, officer: Chief Executive Officer | 2025-03-21 | A-Award | 2.7972 | 2025-03-24 |
| Kowieski Mark | officer: Chief Financial Officer | 2025-03-20 | A-Award | 3.214 | 2025-03-24 |
| D'Onofrio Matthew J | director, officer: Chief Executive Officer | 2025-02-28 | A-Award | 3.65 | 2025-03-03 |
| PYSZCZYMUKA GREG | director | 2025-02-20 | A-Award | 5.26 | 2025-02-24 |
| PYSZCZYMUKA GREG | director | 2025-02-20 | 0 | 2025-02-24 | |
| Nantahala Capital Management, LLC | 10 percent owner | 2025-01-28 | S-Sale | 4.3871 | 2025-01-30 |
| D'Onofrio Matthew J | director, officer: Chief Executive Officer | 2025-01-28 | A-Award | 4.45 | 2025-01-29 |
| WIDDER KENNETH J | director | 2025-01-28 | A-Award | 4.45 | 2025-01-29 |
| REED VICKIE S | director | 2025-01-28 | A-Award | 4.45 | 2025-01-29 |
| Hill Malcolm R | director | 2025-01-28 | A-Award | 4.45 | 2025-01-29 |
| Brady Todd C | director | 2025-01-28 | A-Award | 4.45 | 2025-01-29 |
| GARNER CAM L | director | 2025-01-28 | A-Award | 4.45 | 2025-01-29 |
| Kowieski Mark | officer: Chief Financial Officer | 2025-01-28 | A-Award | 4.45 | 2025-01-29 |
| CARLSON MARILYN R. | officer: Chief Medical Officer | 2025-01-28 | A-Award | 4.45 | 2025-01-29 |
| Nantahala Capital Management, LLC | 10 percent owner | 2024-11-06 | 0 | 2024-11-15 | |
| Nantahala Capital Management, LLC | 10 percent owner | 2024-02-13 | 0.0001 | 2024-11-15 | |
| Nantahala Capital Management, LLC | 10 percent owner | 2024-02-13 | 8.16 | 2024-11-15 | |
| Nantahala Capital Management, LLC | 10 percent owner | 2024-02-13 | 8.16 | 2024-11-15 | |
| Nantahala Capital Management, LLC | 10 percent owner | 2029-02-13 | 8.16 | 2024-11-15 | |
| Nantahala Capital Management, LLC | 10 percent owner | 2024-09-27 | 0.01 | 2024-11-15 | |
| Nantahala Capital Management, LLC | 10 percent owner | 2024-09-27 | 0.01 | 2024-11-15 | |
| Smeal Benjamin C. | director | 2024-10-18 | A-Award | 5.51 | 2024-10-22 |
| Smeal Benjamin C. | director | 2024-10-18 | 0 | 2024-10-22 | |
| Kowieski Mark | officer: Chief Financial Officer | 2024-08-07 | A-Award | 5.27 | 2024-08-08 |
| CARLSON MARILYN R. | officer: Chief Medical Officer | 2024-08-07 | A-Award | 5.27 | 2024-08-08 |
| D'Onofrio Matthew J | director, officer: Chief Executive Officer | 2024-08-07 | A-Award | 5.27 | 2024-08-08 |
| Kowieski Mark | officer: Chief Financial Officer | 2024-05-22 | 0 | 2024-05-30 | |
| Kowieski Mark | officer: Chief Financial Officer | 2024-05-22 | 4.01 | 2024-05-30 | |
| Kowieski Mark | officer: Chief Financial Officer | 2024-05-22 | 2.09 | 2024-05-30 | |
| Hill Malcolm R | director | 2024-05-22 | A-Award | 0.451 | 2024-05-24 |
| GARNER CAM L | director | 2024-05-22 | A-Award | 0.451 | 2024-05-24 |
| REED VICKIE S | director | 2024-05-22 | A-Award | 0.451 | 2024-05-24 |
| WIDDER KENNETH J | director | 2024-05-22 | A-Award | 0.451 | 2024-05-24 |
| Brady Todd C | director | 2024-05-22 | A-Award | 0.451 | 2024-05-24 |
| WIDDER KENNETH J | director | 2023-05-10 | A-Award | 2.12 | 2023-05-11 |
| REED VICKIE S | director | 2023-05-10 | A-Award | 2.12 | 2023-05-11 |
| Hill Malcolm R | director | 2023-05-10 | A-Award | 2.12 | 2023-05-11 |
| GARNER CAM L | director | 2023-05-10 | A-Award | 2.12 | 2023-05-11 |
| Brady Todd C | director | 2023-05-10 | A-Award | 2.12 | 2023-05-11 |
| Gonyer David A | director, officer: CEO | 2023-02-08 | A-Award | 4.01 | 2023-02-10 |
| D'Onofrio Matthew J | officer: President & Chief Op. Officer | 2023-02-08 | A-Award | 4.01 | 2023-02-10 |
| CARLSON MARILYN R. | officer: Chief Medical Officer | 2023-02-08 | A-Award | 4.01 | 2023-02-10 |
| WIDDER KENNETH J | director | 2022-04-27 | A-Award | 0.66 | 2022-04-28 |
| WIDDER KENNETH J | director: | 2022-04-27 | A-Award | 0 | 2022-04-28 |
| REED VICKIE S | director: | 2022-04-27 | A-Award | 0 | 2022-04-28 |
| Hill Malcolm R | director | 2022-04-27 | A-Award | 0.66 | 2022-04-28 |
| Hill Malcolm R | director: | 2022-04-27 | A-Award | 0 | 2022-04-28 |
| GARNER CAM L | director | 2022-04-27 | A-Award | 0.66 | 2022-04-28 |
| GARNER CAM L | director: | 2022-04-27 | A-Award | 0 | 2022-04-28 |
| Brady Todd C | director: | 2022-04-27 | A-Award | 0 | 2022-04-28 |
| Brady Todd C | director | 2022-04-27 | A-Award | 0.66 | 2022-04-28 |
| Gonyer David A | director, officer: President and CEO | 2022-02-02 | A-Award | 0.55 | 2022-02-04 |